Stockreport

Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg [Yahoo! Finance]

Alvotech - Ordinary Shares  (ALVO) 
PDF biosimilar medicines for patients worldwide, today announced that it has reached a licensing and settlement agreement with Regeneron and Bayer, resolving all remaining p [Read more]